1-4 of 4
Nader Sanai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 0 Trial of Ceritinib in Patients with Brain Metastases and Recurrent Glioblastoma

Shwetal Mehta, Roberto Fiorelli, Xun Bao, Chelsea Pennington-Krygier, Alanna Derogatis, Seongho Kim, Wonsuk Yoo, Jing Li, Nader Sanai
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (2): 289–297.
https://doi.org/10.1158/1078-0432.CCR-21-1096
Published: 19 January 2022
View article titled, A Phase 0 Trial of Ceritinib in Patients with Brain Metastases and Recurrent Glioblastoma
Open the PDF for A Phase 0 Trial of Ceritinib in Patients with Brain Metastases and Recurrent Glioblastoma in another window
Journal Articles

A Phase 0 Trial of Ribociclib in Recurrent Glioblastoma Patients Incorporating a Tumor Pharmacodynamic- and Pharmacokinetic-Guided Expansion Cohort

An-Chi Tien, Jing Li, Xun Bao, Alanna Derogatis, Seongho Kim, Shwetal Mehta, Nader Sanai
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (19): 5777–5786.
https://doi.org/10.1158/1078-0432.CCR-19-0133
Published: 01 October 2019
View article titled, A Phase 0 Trial of Ribociclib in Recurrent Glioblastoma Patients Incorporating a Tumor Pharmacodynamic- and Pharmacokinetic-Guided Expansion Cohort
Open the PDF for A Phase 0 Trial of Ribociclib in Recurrent Glioblastoma Patients Incorporating a Tumor Pharmacodynamic- and Pharmacokinetic-Guided Expansion Cohort in another window
Includes: Supplementary data
Journal Articles

Phase 0 Trial of AZD1775 in First-Recurrence Glioblastoma Patients

Nader Sanai, Jing Li, Julie Boerner, Karri Stark, Jianmei Wu, Seongho Kim, Alanna Derogatis, Shwetal Mehta, Harshil D. Dhruv, Lance K. Heilbrun, Michael E. Berens, Patricia M. LoRusso
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (16): 3820–3828.
https://doi.org/10.1158/1078-0432.CCR-17-3348
Published: 14 August 2018
View article titled, Phase 0 Trial of AZD1775 in First-Recurrence Glioblastoma Patients
Open the PDF for Phase 0 Trial of AZD1775 in First-Recurrence Glioblastoma Patients in another window
Includes: Supplementary data
Journal Articles

Quantitative and Mechanistic Understanding of AZD1775 Penetration across Human Blood–Brain Barrier in Glioblastoma Patients Using an IVIVE–PBPK Modeling Approach

Jing Li, Jianmei Wu, Xun Bao, Norissa Honea, Youming Xie, Seongho Kim, Alex Sparreboom, Nader Sanai
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (24): 7454–7466.
https://doi.org/10.1158/1078-0432.CCR-17-0983
Published: 14 December 2017
View article titled, Quantitative and Mechanistic Understanding of AZD1775 Penetration across Human Blood–Brain Barrier in Glioblastoma Patients Using an IVIVE–PBPK Modeling Approach
Open the PDF for Quantitative and Mechanistic Understanding of AZD1775 Penetration across Human Blood–Brain Barrier in Glioblastoma Patients Using an IVIVE–PBPK Modeling Approach in another window
Includes: Supplementary data